From: Central serous retinopathy associated with topical oral corticosteroid use: a case report
Class/Potency | Formulation | Brand-name |
---|---|---|
Class I: Highest potency | ||
Betamethasone dipropionate 0.05% | Ointment/Gel/Lotion | Diprogenta® 0.05% cream, Diprosone® 0.05% ointment/cream |
Clobetasol propionate 0.05% | Ointment | Temovate® 0.05% ointment mixed in Orabase® |
Fluocinolone acetonide 0.1% | Cream/Ointment | Compound mixed in Orabase® |
Halobetasol propionate 0.05% | Cream/Ointment | Ultravate® 0.05% ointment mixed in Orabase® |
Betamethasone sodium phosphate 0.5 mg per 5 ml | Oral rinse | Betamethasone sodium phosphate 0.5 mg mixed in 5 ml water |
Class II: Higher potency | ||
Fluocinolone acetonide 0.05% | Gel/Ointment | Lidex® mixed in Orabase® |
Mometasone furoate 0.1% | Cream | Elocom® 0.1% cream |
Fluticasone propionate 0.05% | Cream | Cutivate® 0.05% cream |
Fluticasone propionate 0.005% | Ointment | Cutivate® 0.005% ointment |
Class III: Moderate potency | ||
Betamethasone valerate 0.05–0.1% | Cream/Ointment | Betnovate®, Diprosone®, Valisone® 0.1% ointment mixed in Orabase® |
Triamcinolone acetonide 0.1% | Dental paste | Oracort® 0.1% paste, Kenalog® 0.1% mixed in Orabase® |
Fluocinolone acetonide 0.025% | Ointment/Gel/Cream | Abricort® 0.025% ointment, Flucinar® 0.025% ointment, Synalar® 0.025% ointment |
Alclometasone dipropionate 0.05% | Ointment/Cream | Aclovate® 0.05% ointment mixed in Orabase® |
Class IV: Lower potency | ||
Fluocinolone acetonide 0.01% | Solution | Synalar® 0.01% ointment |
Hydrocortisone 1.0–2.5% | Cream/Ointment, lotion | Hydrocortisone 1.0–2.5% cream |
Dexamethasone 0.1% | Elixir/Solution | Rinsed or mixed in Orabase® |